Discover 774 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 774
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
for
Advanced Lung Non-Small Cell Carcinoma,
Location: Brewer ME, South Weymouth MA, Boston MA, Brighton MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 70+
Code: NCT06096844
Phase 3, Recruiting
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
for
Locoregional Recurrence,
Location: Boston MA, New York NY, New Brunswick NJ, Hershey PA,
Sponsor: Oana Danciu
Sex: All
Age: 18+
Code: NCT05467891
Phase 2, Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
for
Diffuse Intrinsic Pontine Glioma,
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: University of California, San Francisco
Sex: All
Age: 2 - 39
Code: NCT05009992
Phase 2, Recruiting
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
for
Growth Hormone Deficiency
Location: Manchester NH, Lebanon NH, New Hyde Park NY,
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
for
HER2-positive Advanced Solid Tumor
Location: Boston MA, Shirley NY, Lake Success NY, New York NY,
Sponsor: DualityBio Inc.
Sex: All
Age: 18+
Code: NCT05150691
Phase 1, Phase 2, Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: Worcester MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase 2, Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors